USPSTF Does Not Recommend Routine Thyroid Cancer Screening

Share this content:
USPSTF Does Not Recommend Routine Thyroid Cancer Screening
USPSTF Does Not Recommend Routine Thyroid Cancer Screening

TUESDAY, May 9, 2017 (HealthDay News) -- Clinicians should not routinely screen adults for thyroid cancer if they have no symptoms or warning signs of the disease, according to a final recommendation statement issued by the U.S. Preventative Services Task Force and published in the May 9 issue of the Journal of the American Medical Association.

The Task Force reviewed the available evidence on the benefits and risks of screening. The panel reaffirmed the guidelines it issued in 1996 and 2016.

While screening for the disease does increase the number of people diagnosed with thyroid cancer, it doesn't reduce mortality rates associated with the disease, the Task Force concluded.

"Overdiagnosis occurs because screening for thyroid cancer often identifies small or slow growing tumors that might never affect a person during their lifetime," Task Force member Seth Landefeld, M.D., of the University of Alabama at Birmingham, said in a statement. "People who are treated for these small tumors are exposed to serious risks from surgery or radiation, but do not receive any real benefit."

Evidence Report
Recommendation Statement
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths